Dipharma Group News Today

The Caronno Pertusella site (Italy) is the second Dipharma manufacturing facility to receive ANVISA certificationMILAN, Italy, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Dipharma Francis S.r.l. (Dipharma), a leading Contract Development and Manufacturing Organization (CDMO) and a global manufacturer of Active Pharmaceutical Ingredients, announced today another new production site of the Group, the facility located in Caronno Pertusella, near Milan (Italy), has received the Good Manufacturing Practice (GM

The Baranzate site (Italy) is the first Dipharma manufacturing facility to receive Anvisa certification...

Thanks to the approval by the Italian Medicines Agency (AIFA), the Company increases its efficiency and is able to face the growing demand for its services. Dipharma Francis S.r.l. (Dipharma), a leading

The achievement ratifies Dipharma's commitment to sustainability Dipharma Francis, a global world class Contract Development and Manufacturing Organization (CDMO) and a leading manufacturer of APIs

Dipharma Francis ("Dipharma"), a global CDMO and a leading manufacturer of APIs and intermediates for generic and contract manufacturing markets, is pleased to announce that Kalexsyn, Inc., a Michigan

Press release content from Business Wire. The AP news staff was not involved in its creation.